Filter
1555
Filtered Results: 1555
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
179
New Publications
475
Language
Document type
No document type
1014
Studies & Reports
189
Guidelines
184
Manuals
76
Strategic & Response Plan
39
Training Material
19
Fact sheets
14
Situation Updates
12
Infographics
5
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
98
Kenya
50
Western and Central Europe
42
Uganda
41
Ethiopia
41
Global
40
South Africa
35
Nigeria
33
Tanzania
31
Zambia
30
Namibia
27
Ghana
26
Nepal
25
Eastern Europe
24
Malawi
22
Liberia
22
Myanmar / Burma
22
Bangladesh
20
Rwanda
18
Philippines
18
Ukraine
16
Africa
16
Asia
16
Lesotho
15
Sierra Leone
15
Latin America and the Carribbean
15
Cambodia
14
Russia
14
Colombia
10
Zimbabwe
10
South–East Asia Region
10
Senegal
9
Botswana
9
Indonesia
9
Mozambique
8
Venezuela
7
Germany
6
Eswatini/ Swaziland
6
Thailand
5
Benin
5
Peru
5
Bolivia
5
Vietnam
5
Moldova
5
Pakistan
5
Tajikistan
4
Cameroon
4
Syria
4
East and Southern Africa
4
Timor Leste/ East Timor
3
Albania
3
Afghanistan
3
Paraguay
3
Ecuador
3
China
2
Laos
2
Haiti
2
Jordan
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Turkmenistan
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Yemen
2
Georgia
2
Poland
2
Libya
2
Somalia
2
North Macedonia
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Estonia
1
Burkina Faso
1
Uzbekistan
1
Qatar
1
USA
1
Hungary
1
Saudi Arabia
1
Congo, Democratic Republic of
1
Western Pacific Region
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Brazil
1
Sri Lanka
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Mali
1
Bhutan
1
South Sudan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
669
Clinical Guidelines
175
Public Health
74
Women & Child Health
52
Pharmacy & Technologies
27
Key Resources
24
Capacity Building
20
Toolboxes
TB
371
HIV
188
AMR
65
Pharmacy
61
NTDs
41
COVID-19
40
Mental Health
38
NCDs
24
Caregiver
22
Malaria
22
Global Health Education
19
Refugee
16
Ebola & Marburg
13
Conflict
13
Polio
13
Planetary Health
11
Rapid Response
9
Health Financing Toolbox
8
Disability
7
Natural Hazards
6
Specific Hazards
3
Cholera
1
Social Ethics
1
2.0 Rapid Response
1
Zika
1
Unofficial Translation
Approved by the Federal Government on October 20, 2016
Frequently Asked Questions on Visceral Leishmaniasis
Overcoming HIV-related stigma and discrimination in health- care settings and beyond
UNAIDS 2017 | REFERENCE
Standard Treatment Guideline
6th edition. The HIV epidemic Namibia is gradually being brouhgt under countrol as demonstrated by results in the preliminary report of Namibia Population-Based HIV Impact Assessment (NAMPHIA), a cross-sectional household-based survey that was conducted in 2017. Currently, it is estimated that about...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex...
The National Strategic Plan for Malaria Elimination in India (2023-2027) focuses on achieving malaria elimination by 2030, in alignment with the Global Technical Strategy. The document outlines the strategies, targets, and goals for malaria elimination, aiming for zero indigenous malaria cases by 20...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin...
The annual bulletin of the Mekong Malaria Elimination (MME) programme is a yearly report that reviews ongoing efforts to combat multidrug resistance and eliminate malaria in the 6 countries of the Greater Mekong subregion (GMS): Cambodia, China (Yunnan province), Lao People's Democratic Republic, My...
